Hide Board Information

Show Board Information

Danimer Scientific, Inc. DNMR

Board Mod: Add me as mod

Asst Mods:

Last Post: 12/30/2024 7:55:27 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 8

Danimer Scientific, Inc. (NYSE: DNMR) Stock Message Board

1. DNMR Company Profile

    

2. DNMR Time & Sales

    

3. DNMR Recent News

    

4. DNMR Filings

    

5. DNMR Financials

    

6. DNMR Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	DNMR delist from NYSE, 12/31/2024 OTC	Steel Reserve	12/30/2024 7:55:27 PM
5	$DNMR 27% v10,9M c2.55 f101,388M H2.66 RL1.96	znewcar1	02/24/2023 6:48:57 PM
4	$DNMR hod 2.59 BO2.7 Over $5ish HH66.3 Danimer	znewcar1	02/24/2023 1:00:12 PM
3	$DNMR strong BO2.5 hod2.55 MH2.78 ML1.96 LL1.59	znewcar1	02/24/2023 12:56:59 PM
2	S@$4? @ 5.10 20dma@6.2	znewcar1	01/31/2022 12:33:42 PM
1	DNMR 20% v4,2M c17.77 f97,7M	znewcar1	11/01/2021 6:51:22 PM

Recent Articles

• SEGG Media Celebrates Nasdaq Compliance Milestone for Growth
• Altisource Portfolio Solutions Announces Q3 Earnings Call Details
• FastPassCorp Converts Debt to Equity for Stronger Growth
• Whiskey JYPSI Celebrates Revolution with Legacy Batch 003
• Transformative Patient Stories Shared at Nuvia Event
• Trident Development's Orchard Place Apartments Enhance Twin Cities Living
• Transforming Insurance Analytics: Growth Driven by Innovation
• Revolutionary Lactose-Free Sauce Set to Change Cooking
• Addressing Prescription Drug Misuse: A Community Call-to-Action
• Exploring the Future of the Rigid Endoscopes Market Trends
• Empowering Athletes: The San Diego Triathlon Challenge Ahead
• Empowering Families: Combatting Prescription Drug Misuse Together
• Exploring Growth Opportunities in the Pulse Ingredients Market
• Empowering Grassroots: A Great Idea’s New Microgrant Initiative
• Summit Therapeutics Stock Update: Key Developments and Insights
• Empowering Communities in the Fight Against Drug Misuse
• Health Data Analytics Institute Enhances Patient Care with AI
• Community Initiative Aims to Combat Prescription Drug Abuse
• Important Update for PubMatic Investors: Act Before Deadline
• Norwegian Cruise Line's Renewable Fuel Partnership with Repsol
• Empowering Physicians Through AI and Digital Health Innovation
• Discovering the Growth of Your Investment in Simon Property Group
• Exploring the Future of Space Propulsion Systems and Opportunities
• NB HASH RWA: The Emerging Leader in Stable Digital Investments
• Sonatype Elevate Awards 2025: Honoring Innovators in Software
• Exploring Innovative Treatments for Alcohol Withdrawal at Spark Biomedical
• Exploring GYMD Digital Technology's Innovations in AI at Tech Week
• Raptive Enhances Opportunities for Independent Creators
• Key Insights for Snap Inc. Investors Amid Lawsuit Deadline
• Brandon Hall Group Welcomes David Wentworth as New Leader
• Nutex Health Investors Encouraged to Review Legal Options
• Exciting Opportunities Ahead with Arizent's 2026 Media Kits
• Exploring Revolutionary Advancements in Space Propulsion Systems
• Celebrating Innovation: The 2025 Elevate Award Winners
• BOPP Films Expected to Reach $50.16 Billion Market by 2034
• Standard Lithium Secures $130 Million in Recent Offering
• Exploring the Surge of Rigid Plastic Packaging in E-Commerce
• Exploring Morningstar Inc.'s Current Market Performance Metrics
• Examining Snowflake's Recent Trading Signals for Investors
• Promising Clinical Advances of Anzu-cel Therapy in Uveal Melanoma
• Analyzing Market Moves: Robinhood Options Trading Insights
• Minerals Technologies Invests in Renewable Fuel Production Growth
• Exploring the Bullish Trends in Novo Nordisk's Options Market
• LOBO EV Technologies Plans Innovative EV Manufacturing Hub
• Major Stock Movements: Key Players Surge in Recent Session
• Denny's Offers Free Grand Slams for Celebratory Home Runs
• BNP Paribas Optimistic About Overturning Sudan Litigation Verdict
• Briggs Freeman Sotheby's Expands Luxury Services in Dallas
• ISC Strengthens Community Support through Art Partnership
• Transforming Real Estate with MRI Software's New AI Tool